Pharma Middle East November 02-04, 2015 Dubai, UAE

OMICS International Conferences invites all the participants across the globe to attend the "Pharma Middle East Conference” slated on November 02-04, 2015 at Dubai, UAE.

OMICS International is a leading scientific event organizer, a pioneer and a union of open access publications, conferences, workshops, symposiums and exhibitions. OMICS International was established in the year 2007 and at present has pioneered the scientific world by publishing articles in about 400 Open Access Journals, conducting over 300 Scientific Meetings and numerous B2B Meetings. OMICS International is basking in the glory of success with the support of more than 1000 scientific associations, 30,000 editorial board members, and has gained 3.5 million followers in a span of 6 years to add to its credit. OMICS International Conferences are scientific rostrums to unveil the novel developments and analyze the advantages and consequences by conglomerating au courant information in Science and Technology. Omics International Conferences has designed many UAE Pharma Conferences. OMICS International also organizes many Middle East events 2015 which include medical and Pharma conferences in UAE  where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions. OMICS International has started Pharma conferences in different continents all over the world like Middle East Pharma Conferences.

Pharma Middle East Conference which is an International Pharmacy Conference is a scientific platform to meet fellow key decision makers all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, CROs supply chain, Logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world.Pharma Middle East will be one of the outstanding Middle East Pharma Conferences. 

OMICS International Conference Series provides a broad view of all the conferences along with past and up coming conferences all over the world. 

Market Analysis

The Pharma Industry is responsible for the development, production and marketing of medications. According to IMS Health Consulting, an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the global pharmaceutical market is expected to reach $1.1 trillion by 2015 and will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. The global demographic, epidemiological and economic changes are transforming the pharmaceutical market. The world population is growing rapidly and is projected to rise from 7 billion in 2011 to 7.7 billion in 2020 and 9.6 billion in 2050, hence an increase in the demand for pharmaceuticals. The global pharmaceuticals market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. Economically, the Middle East (ME) is well positioned to be the one of next growth engine of global pharmaceutical business: several countries in the region enjoy robust economic growth and the highest cash reserves per capita in the world. The pharmaceutical Industry is consequently flourishing as the expanding middle class demands better care, and government healthcare spending continues to grow. The pharmaceutical market in the Middle East is likely to grow by between ten and 15 percent annually over the next three years, outstripping more mature markets, forecasts a report from URCH Publishing. The Middle East pharma markets are showing consistent growth over the last years in particular in the area of specialized medication. The market for pharmaceutical products is still expected to grow in many countries across the region.

• The Middle East pharma market was valued at $14.8bn in 2008, registering a y-o-y sales growth of 12.6%, and is forecast to return at a CAGR of 8.1% between 2008 and 2014 to reach a total value of 23.5bn by the end of 2014. The general anti-infective market is expected to generate the highest sales of $3.9bn by the end of 2014, followed by alimentary canal & metabolic disorders at $3.7bn.

• General anti-infectives, alimentary canal & metabolism and cardiovascular disorders remained as top selling therapeutic categories in the Middle East, while registering 2008 sales of $2.6bn, $2.3bn and $1.9bn respectively.
• The leading brands in the Middle East pharmaceutical market had a predominance of respiratory and cardiovascular drugs. However, the top 10 brands constituted a very small fraction of the Middle East market, with other drugs making up 94.1% of the total market in 2008. GSK's asthma and COPD drug Seretide dominated the market with 2008 sales of $134m, a strong growth of 21% over 2007
• This growth in Pharmacutical Business promises the growth of Pharma jobs in Middle East Countries.

Track 1: Pharmacological Sciences

The science that deals with the origin, nature, chemistry, effects, and uses of drugs; it includes Pharmacognosy, Pharmacokinetics, Pharmacodynamics, Pharmacotherapeutics, and Toxicology 

This session is dealt with many sub disciplines such as Clinical Pharmacology, Neuropharmacology,  Psychopharmacology, Pharmacogenetics, Pharmacogenomics, Pharmacoepidemiology,Systems Pharmacology, Toxicology, Theoretical Pharmacology, Posology, Pharmacognosy, Behavioral Pharmacology, Environmental pharmacology, Dental Pharmacology, Medical Pharmacology, Endocrine pharmacology etc., These topics will be discussed in Pharma Middle East giving a large scope for Pharmaceutical Research Conferences.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 2: Bio-Pharmaceutical Sciences

Biopharmaceutical science involves the creation of medical drugs by artificially growing some or all of their components. It is the pluridisciplinar background on the discovery phase of the drug development process, at advanced level. This field includes the study of molecular mechanisms of disease, potential therapeutic targets and therapeutic strategies.

The Session discusses on recent trends in pharmaceutical research, in which increasing numbers of drugs are coming from large biopharmaceutical molecules. Bio-Pharmaceutical Sciences session includes talks on diversified fields like Biopharmaceutics and drug disposition, Innovations in clinical development, Pharmaceutical technology, Drug discovery and design, Pharmaceutics and drug delivery, Routes of administration, Fundamental drug development and etc....

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 3: Pharmaceutical Chemistry and Medicinal Chemistry

Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

This particular session involves discussion on synthetic and computational aspects of the study of existing drugs and agents in development in relation to their bioactivities (biological activities and properties), i.e., understanding their structure-activity relationships (SAR). Pharmaceutical chemistry is focused on quality aspects of medicines and aims to assure fitness for purpose of medicinal products.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 4: Nanotechnology

Nanotechnology is being employed in the pharmaceutical field for many reasons, but perhaps the leading goals are to improve drug solubility/bio-availability and/or delivery to various sites of action. Nanotechnology is also being employed to develop new and improved therapeutic devices. Therapeutics are enhanced through both the improved drug delivery, drug targeting and bioavailability of existing medicinal substances, as well as the discovery of entirely new substances and nanomaterials, which introduces a range of advantages over classical drug-delivery methods, including the targeted delivery to diseased sites only, and the improved adsorption, distribution and duration of medicines in the body. Pharma Middle East is an International Conference in Dubai, UAE.

Nanotechnology is dealt with discussions on topics like nanomedicine, tissue engineering, nanorobots, biosensors, nanomaterials, biomarkers, image enhancement devices and implant technology.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 5: Drugs and Regulations

Drugs are not ordinary consumers’ products. In most instances, consumers are not in a position to make decisions about when to use drugs, which drugs to use, how to use them and to weigh potential bene- fits against risks as no medicine is completely safe. Professional advise from either prescribers or dispensers are needed in making these decisions.

The topics in this session include Regulations and organizations, Clinical Pharmacy Services: patient compliance, Health care management and providers, Implimentation of pharmacogenetics in USA, Drug safety, Drug rediscovery, Multiple drug use, Good governance in pharmacy and etc.......

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 6: Industrial Pharmacy and Pharmacy Practice

By definition industrial pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities. This broad research area relates to different functions in pharmaceutical industry and having contact areas with engineering and economics.

Pharmacy practice is the discipline of pharmacy which involves developing the professional roles of pharmacists. Disease-state management, Clinical interventions (refusal to dispense a drug, recommendation to change and/or add a drug to a patient's pharmacotherapy, dosage adjustments, Professional development, Pharmaceutical care, Extemporaneous pharmaceutical compounding, Patient care, Drug abuse prevention, Prevention of drug interactions, including drug-drug interactions or drug-food interactions, Prevention (or minimization) of adverse events, Incompatibility, Drug discovery and evaluation, Community Pharmacy etc,.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 7: Ethics in Pharmacy

The philosophy of pharmacy practice acknowledges pharmacists as health professionals with the knowledge, skills and attributes to take responsibility for the management and utilisation of medicines, in order to optimise medicines related health outcomes. Pharmacy practice includes the technical aspects of pharmacy services, preparation of pharmaceuticals and medicines supply management as well as patient-centred care with counselling, providing drug information and monitoring drug therapy.

This session deals with topics like FDCA, NDA, Adulteration, Misbranding, Exemption in prescription, Experimental animal ethics, Human trial ethics and etc....

Track 8: Preformulation Studies and Techniques

Preformulation studies are an essential component of drug development wherein it supports development of formulations, for different stages of clinical trials. The word preformulation is composed of two words pre and formulation. Activities done prior to formulation development are called as preformulation studies. It provides the scientific basis for formulation development.

Topics discussed in this session are Solubility, dissociation constant (pKa), salt formation, partition or distribution coefficient (log P or log D), pH solubility profile and dissolution kinetics, polymorphism, solvated forms and amorphous form and solid state stability and solution state stability, characterization of particle properties like morphology ,bulk density, flow properties and compaction behavior.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 9: Green Chemistry in Pharmaceutical Industry

Green chemistry, also called sustainable chemistry, is a philosophy of chemical research and engineering that encourages the design of products and processes that minimize the use and generation of hazardous substances. As a chemical philosophy, green chemistry applies to organic chemistry, inorganic chemistry, biochemistry, analytical chemistry, physical chemistry and even chemical engineering.

Target Audience for this particular session includes academicians, researchers, health care logistic       practitioners, Business professionals, students etc.,

Track 10: Clinical Pharmacy and Pharmacotherapeutics

Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health, wellness, and diseaseprevention.

              This session deals with topics like  basic components of clinical pharmacy practice Prescribing drugs , Administering drugs,Documenting professional services,Reviewing drug use,Counseling,Consulting,Preventing Medication Errors etc.,

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Pharmacists, Business professionals, students etc.,

Track 11: Pharmaceutical Microbiology and Biotechnology

                    Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals e.g.minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial by-products like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile.

This session includes discussions on aspects of pharmaceutical microbiology include the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.

Target Audience for this particular session includes academicians, researchers, health care logistic practitioners, Business professionals, students etc.,

Track 12: Pharmacognosy and Phytochemistry

Pharmacognosy is the study of medicines derived from natural sources. Most pharmacognostic studies focus on plants and medicines derived from plants, other types of organisms are also regarded as pharmacognostically interesting, in particular, various types of microbes (bacteria, fungi, etc.), and, recently, various marine organisms.

           This topic is dealt with topics like Medical Ethnobotany,Ethnopharmacology,Phytotherapy,Phytochemistry, Phytoconstituents,Zoopharmacognosy,Marine Pharmacognosy etc.,

Target Audience for this particular session includes academicians,researchers,health care logistic practitioners, Business professionals,students etc.,

Pharma Middle East will be instrumental in the mission of disseminating the scientific knowledge and information through its worldwide international Science Congresses. It will be one of the best Pharmaceutical and Medical conferences in UAE.